VCG
GMED icon

Vantage Consulting Group’s Globus Medical GMED Stock Holding History

Vantage Consulting Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-310
Closed -$20K – 685
2020
Q4 		$20K Buy
+310
New +$17.8K ﹤0.01% 866

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Vantage Consulting Group's GMED Position: Q1 2021 in Review

Vantage Consulting Group sold out of Globus Medical (GMED) in Q1 2021, closing a stake of 310 shares — an estimated $20K sold.

Vantage Consulting Group first reported a position in GMED in Q4 2020 and held it in 1 quarter. The position peaked at $20K in Q4 2020. 345 funds tracked by Wall St. Rank hold GMED as of Q1 2021.

  • Vantage Consulting Group reported no remaining Globus Medical position as of Q1 2021 after selling out during the quarter.
  • Vantage Consulting Group sold 310 Globus Medical shares in Q1 2021, an estimated $20K.
  • Vantage Consulting Group first reported a position in Globus Medical in Q4 2020 and held it in 1 quarter.
  • Vantage Consulting Group's Globus Medical position peaked at $20K in Q4 2020.
  • 345 funds tracked by Wall St. Rank held Globus Medical as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.